(Q38023251)

27 August 2017

title

In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards (English)

1 reference

27 August 2017

2

1 reference

27 August 2017

Frank Møller Aarestrup

series ordinal

3

object named as

Frank M Aarestrup

1 reference

27 August 2017

Romney M Humphries

1

1 reference

27 August 2017

Janet A Hindler

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

2 July 2012

1 reference

Clinical Infectious Diseases

27 August 2017

published in

1 reference

27 August 2017

volume

55

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

1107-1113

1 reference

FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Nontyphoidal salmonellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

The global burden of nontyphoidal Salmonella gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Practice guidelines for the management of infectious diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Invasive non-Typhi Salmonella disease in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

A study of typhoid fever in five Asian countries: disease burden and implications for controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

International spread of an epidemic population of Salmonella enterica serotype Kentucky ST198 resistant to ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Molecular characterization and antimicrobial susceptibility of Salmonella isolates from infections in humans in Henan Province, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Fluoroquinolone-resistant typhoid, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

The emergence of antibiotic resistance in typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Typhoid fever in the United States, 1999-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Quinolone-resistant Salmonella Typhi in South Africa, 2003-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Evolutionary history of Salmonella typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Quinolone-resistant Salmonella typhi in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Development of quinolone resistance in salmonella: failure to prevent splenic abscess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Quinolone resistance in salmonella: clinical experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Fluoroquinolone resistance in Salmonella Typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Salmonella enterica Serotype Typhi with nonclassical quinolone resistance phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Is plasmid-mediated quinolone resistance a clinically significant problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Plasmid-mediated quinolone resistance determinant qnrS1 detected in Salmonella enterica serovar Corvallis strains isolated in Denmark and Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

The worldwide emergence of plasmid-mediated quinolone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

In vivo selection of aac(6')-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS600

21 January 2018

Identifiers

DOI

10.1093/CID/CIS600

1 reference

27 August 2017

1 reference